Targeted Therapy of Uveal Melanoma: Recent Failures and New Perspectives.
driver mutations
signaling pathways
targeted therapies
uveal melanoma
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
18 Jun 2019
18 Jun 2019
Historique:
received:
13
05
2019
revised:
10
06
2019
accepted:
11
06
2019
entrez:
21
6
2019
pubmed:
21
6
2019
medline:
21
6
2019
Statut:
epublish
Résumé
Among Uveal Melanoma (UM) driver mutations, those involving
Identifiants
pubmed: 31216772
pii: cancers11060846
doi: 10.3390/cancers11060846
pmc: PMC6628160
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Associazione Italiana per la Ricerca sul Cancro
ID : IG 17103
Organisme : Compagnia di San Paolo
ID : 20067
Déclaration de conflit d'intérêts
The authors have no conflict of interest to declare.
Références
Melanoma Res. 2019 Dec;29(6):561-568
pubmed: 30664106
Invest Ophthalmol Vis Sci. 2013 Nov 08;54(12):7354-61
pubmed: 24052640
Cancer Cell. 2014 Jun 16;25(6):714-5
pubmed: 24937456
Comput Struct Biotechnol J. 2019 Jan 08;17:136-141
pubmed: 30766662
Mol Cancer Res. 2017 May;15(5):501-506
pubmed: 28223438
Cancer Cell. 2014 Jun 16;25(6):822-30
pubmed: 24882516
J Nat Med. 2013 Jan;67(1):196-201
pubmed: 22388972
Nat Rev Drug Discov. 2014 Sep;13(9):673-91
pubmed: 25131830
Cancer Genet Cytogenet. 1990 Apr;45(2):249-53
pubmed: 2317773
Mol Cancer Ther. 2013 May;12(5):768-76
pubmed: 23443802
J Biol Chem. 2000 Dec 15;275(50):38953-6
pubmed: 11038347
N Engl J Med. 2014 Dec 4;371(23):2189-2199
pubmed: 25409260
J Transl Med. 2017 Jun 23;15(1):145
pubmed: 28645290
Curr Eye Res. 2006 Sep;31(9):775-85
pubmed: 16966150
Pigment Cell Melanoma Res. 2018 Mar;31(2):253-266
pubmed: 28972303
Cell. 2011 Sep 16;146(6):904-17
pubmed: 21889194
Pigment Cell Melanoma Res. 2018 Nov;31(6):661-672
pubmed: 29738114
Cancer Immunol Immunother. 2007 Oct;56(10):1589-95
pubmed: 17410362
Int Immunopharmacol. 2014 Aug;21(2):439-46
pubmed: 24946096
Cancer Metastasis Rev. 2018 Sep;37(2-3):335-345
pubmed: 30094568
BMC Med Genomics. 2018 Nov 06;11(1):97
pubmed: 30400891
Clin Cancer Res. 2017 Sep 1;23(17):5187-5201
pubmed: 28698201
N Engl J Med. 2010 Dec 2;363(23):2191-9
pubmed: 21083380
Science. 2015 Oct 9;350(6257):207-211
pubmed: 26359337
Clin Cancer Res. 2012 Jan 15;18(2):408-16
pubmed: 22038994
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4372-5
pubmed: 16303922
Clin Cancer Res. 2011 Oct 15;17(20):6574-81
pubmed: 21880788
J Oncol. 2018 Dec 02;2018:1908065
pubmed: 30631354
JAMA. 2014 Jun 18;311(23):2397-405
pubmed: 24938562
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7769-E7777
pubmed: 27837027
Clin Cancer Res. 2018 Aug 1;24(15):3741-3754
pubmed: 29233905
Lancet. 1996 May 4;347(9010):1222-5
pubmed: 8622452
Eur J Cancer. 2018 Nov;103:41-51
pubmed: 30205280
ACS Chem Biol. 2019 Jan 18;14(1):132-136
pubmed: 30525429
Genes Dev. 2013 Feb 15;27(4):355-71
pubmed: 23431053
Oncotarget. 2016 Apr 26;7(17):23633-46
pubmed: 26988753
Cancers (Basel). 2018 Mar 28;10(4):
pubmed: 29597279
Invest Ophthalmol Vis Sci. 2008 Jun;49(6):2337-42
pubmed: 18515579
Pathol Res Pract. 2016 Nov;212(11):980-987
pubmed: 27546281
Mol Cancer Ther. 2013 Dec;12(12):2817-26
pubmed: 24140933
PLoS One. 2012;7(1):e29989
pubmed: 22267972
Invest New Drugs. 2017 Feb;35(1):47-58
pubmed: 27650277
Ther Adv Med Oncol. 2018 Feb 21;10:1758834018757175
pubmed: 29497459
Methods Mol Biol. 2018;1731:325-348
pubmed: 29318564
Mol Cancer Ther. 2018 Jun;17(6):1147-1155
pubmed: 29735645
Cancers (Basel). 2019 Mar 05;11(3):
pubmed: 30841549
Biomed Res Int. 2014;2014:141582
pubmed: 25184134
Invest Ophthalmol Vis Sci. 2008 Feb;49(2):636-43
pubmed: 18235009
Mol Cell Oncol. 2014 Dec 01;2(1):e970957
pubmed: 27308390
Cancer Discov. 2018 Jan;8(1):24-36
pubmed: 29263030
Cancer Cell. 2017 Aug 14;32(2):204-220.e15
pubmed: 28810145
Cancer Res. 2001 Jul 1;61(13):5303-6
pubmed: 11431374
Nat Rev Cancer. 2018 Jun;18(6):341-358
pubmed: 29674709
Invest New Drugs. 2013 Oct;31(5):1107-14
pubmed: 23912257
Cancer Discov. 2018 Apr;8(4):458-477
pubmed: 29386193
Oncogene. 2014 Sep 25;33(39):4724-34
pubmed: 24141786
PLoS One. 2012;7(11):e48787
pubmed: 23226204
Oncotarget. 2016 Jan 26;7(4):4624-31
pubmed: 26683228
Nat Rev Clin Oncol. 2017 Aug;14(8):463-482
pubmed: 28374786
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2363-72
pubmed: 10892885
Oncologist. 2016 Mar;21(3):281-2
pubmed: 26911405
Clin Exp Metastasis. 2006;23(1):87-96
pubmed: 16826425
Invest Ophthalmol Vis Sci. 2009 Dec;50(12):5522-8
pubmed: 19553629
J Pathol. 2001 Jun;194(2):201-6
pubmed: 11400149
Oncotarget. 2017 Dec 15;9(5):6174-6187
pubmed: 29464063
Nat Commun. 2015 Dec 14;6:10156
pubmed: 26658454
Am J Pathol. 1998 Apr;152(4):855-63
pubmed: 9546344
Clin Cancer Res. 2012 Aug 15;18(16):4345-55
pubmed: 22733540
Pigment Cell Melanoma Res. 2014 Nov;27(6):1138-48
pubmed: 25124714
Exp Eye Res. 2019 Apr;181:213-222
pubmed: 30771295
Clin Cancer Res. 2012 Jul 1;18(13):3552-61
pubmed: 22550165
Melanoma Res. 2005 Jun;15(3):147-53
pubmed: 15917695
Nature. 2009 Jan 29;457(7229):599-602
pubmed: 19078957
Melanoma Res. 2010 Apr;20(2):126-32
pubmed: 20061986
Cancer Cell. 2014 Jun 16;25(6):831-45
pubmed: 24882515
Clin Cancer Res. 2019 Apr 1;25(7):2206-2218
pubmed: 30563937
Anticancer Res. 2018 Jul;38(7):3817-3824
pubmed: 29970501
Oncotarget. 2016 Jun 7;7(23):33542-56
pubmed: 27507190
Methods Mol Biol. 2014;1102:427-40
pubmed: 24258991
J Ophthalmol. 2016;2016:8734309
pubmed: 26942004
Mol Cancer Ther. 2012 Sep;11(9):1905-14
pubmed: 22653968
Invest Ophthalmol Vis Sci. 2010 May;51(5):2329-37
pubmed: 20042655
J Pathol. 1999 May;188(1):56-62
pubmed: 10398141
Cell. 2007 Feb 23;128(4):683-92
pubmed: 17320506
Eur J Cancer. 2013 Oct;49(15):3353-65
pubmed: 23849826
Oncotarget. 2018 Apr 24;9(31):21674-21686
pubmed: 29774094
J Cell Biochem. 2019 Apr;120(4):5766-5776
pubmed: 30320917
Oncotarget. 2015 Oct 20;6(32):33397-409
pubmed: 26397223
Pigment Cell Melanoma Res. 2013 Mar;26(2):193-204
pubmed: 23176534
J Clin Oncol. 2018 Apr 20;36(12):1232-1239
pubmed: 29528792
Cell. 2015 Jun 18;161(7):1681-96
pubmed: 26091043
Cancer Metastasis Rev. 2017 Mar;36(1):109-140
pubmed: 28229253
Invest Ophthalmol Vis Sci. 2011 Mar 02;52(3):1193-9
pubmed: 21051724
Cell Death Dis. 2014 Feb 13;5:e1059
pubmed: 24525735
Ocul Oncol Pathol. 2017 Jul;3(2):117-121
pubmed: 28868282
Cancer Lett. 2017 Aug 1;400:47-60
pubmed: 28455241
Melanoma Res. 2012 Dec;22(6):440-6
pubmed: 23114504
Invest Ophthalmol Vis Sci. 2016 Apr 1;57(4):1982-90
pubmed: 27096756
Arch Ophthalmol. 2006 Oct;124(10):1428-34
pubmed: 17030710
Expert Opin Ther Targets. 2015 Jan;19(1):97-112
pubmed: 25219541
Science. 2016 Mar 25;351(6280):1463-9
pubmed: 26940869
Mol Cancer Res. 2019 Apr;17(4):963-973
pubmed: 30567972
Oncotarget. 2016 Feb 16;7(7):7816-28
pubmed: 26761211
Invest Ophthalmol Vis Sci. 2014 Aug 21;55(10):6178-86
pubmed: 25146981
J Natl Cancer Inst. 1990 Nov 21;82(22):1765-9
pubmed: 2231772
Eur J Med Chem. 2018 Jun 25;154:354-366
pubmed: 29857221
Genes Dev. 2008 Jul 15;22(14):1962-71
pubmed: 18579750
Clin Cancer Res. 2007 May 15;13(10):2923-7
pubmed: 17504992
Melanoma Res. 2016 Jun;26(3):272-7
pubmed: 26795274
Cancer Res. 2015 Jul 1;75(13):2737-48
pubmed: 25952648
Int J Cancer. 2003 Sep 10;106(4):472-479
pubmed: 12845640
Biomed Microdevices. 2015 Feb;17(1):15
pubmed: 25653058
Mol Cancer Ther. 2014 May;13(5):1044-53
pubmed: 24563540
Cell. 2017 Feb 9;168(4):629-643
pubmed: 28187285
Br J Cancer. 2016 Jun 28;115(1):20-4
pubmed: 27253171
Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):370-375
pubmed: 28011764
Cancer Res. 2005 Dec 1;65(23):10901-11
pubmed: 16322237
EMBO Mol Med. 2019 Feb;11(2):
pubmed: 30610113
Invest Ophthalmol Vis Sci. 2013 Jan 09;54(1):234-43
pubmed: 23188729
Cancer. 2018 Jul 1;124(13):2693-2703
pubmed: 29579316
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5230-4
pubmed: 18719078
Mol Vis. 2012;18:2454-67
pubmed: 23077404
Curr Eye Res. 2007 Mar;32(3):281-90
pubmed: 17453948
Biochim Biophys Acta. 2015 Mar;1849(3):247-56
pubmed: 25497382
Pigment Cell Melanoma Res. 2014 Mar;27(2):297-308
pubmed: 24354797
PLoS One. 2012;7(4):e34038
pubmed: 22485156
Sci Signal. 2019 Mar 19;12(573):
pubmed: 30890659
Clin Cancer Res. 2007 Sep 1;13(17):5219-25
pubmed: 17785578
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2835-42
pubmed: 20089875
Nat Commun. 2018 Jan 9;9(1):116
pubmed: 29317634
Cancer Cell. 2019 Mar 18;35(3):457-472.e5
pubmed: 30773340
JAMA Ophthalmol. 2015 Sep;133(9):1013-21
pubmed: 26068448
ChemMedChem. 2019 Apr 17;14(8):865-870
pubmed: 30790465
J Biol Chem. 2018 Dec 21;293(51):19586-19599
pubmed: 30352874
Exp Eye Res. 2008 Jun;86(6):936-41
pubmed: 18423620
Cancer Cell. 2016 Jun 13;29(6):889-904
pubmed: 27265506
Oncotarget. 2014 Nov 30;5(22):10997-9
pubmed: 25526026
Cancer Res. 2004 Oct 15;64(20):7205-9
pubmed: 15492234
Acta Ophthalmol. 2008 Nov;86 Thesis 4:26-34
pubmed: 19032679
Invest Ophthalmol Vis Sci. 2015 Jan 15;56(3):1447-58
pubmed: 25593028
Dev Ophthalmol. 2012;49:117-136
pubmed: 22042017
Science. 2010 Dec 3;330(6009):1410-3
pubmed: 21051595
Cancer Biol Ther. 2019;20(5):700-710
pubmed: 30571927
Sci Rep. 2016 Mar 04;6:22622
pubmed: 26940009
Annu Rev Biochem. 2019 Jun 20;88:577-604
pubmed: 30566373
Nat Genet. 2016 Jun;48(6):675-80
pubmed: 27089179
Melanoma Res. 2014 Dec;24(6):617-20
pubmed: 25211165
Nat Rev Cancer. 2013 Apr;13(4):246-57
pubmed: 23467301
Mol Cancer Ther. 2017 Mar;16(3):516-528
pubmed: 28138035
Cancer Treat Rev. 2017 Nov;60:44-52
pubmed: 28881222
Curr Eye Res. 2011 Apr;36(4):386-90
pubmed: 21284506
Sci Signal. 2018 Sep 04;11(546):
pubmed: 30181242
Cancers (Basel). 2018 Apr 10;10(4):
pubmed: 29642615
Nat Genet. 2013 Aug;45(8):933-6
pubmed: 23793026
Ophthalmology. 2018 Feb;125(2):210-217
pubmed: 28935400
Mol Cancer. 2012 Apr 19;11:22
pubmed: 22515704
Clin Genet. 2018 May;93(5):952-961
pubmed: 28902406
Br J Cancer. 2009 Sep 1;101(5):813-5
pubmed: 19654573